Proprotein convertase subtilisin/kexin type 9 (PCSK9) modulates cholesterol homeostasis and neuroinflammation in cell models of astrocytes and neurons
High cholesterol absorption is associated with increased cardiovascular risk in hemodialysis patients: insights from the aurora study
Debate: Who needs injectable therapies for cholesterol lowering? Statins and ezetimibe are enough for CVD prevention – Discussion and Q&A
Efficacy of a novel PCSK9 inhibitory peptide alone and in combination with an anti-ANGPTL3 monoclonal antibody in a mouse model of atherosclerosis